down arrow

Bio-Rad Laboratories, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US0905722072
USD
320.06
-0.28 (-0.09%)

Dec 04

NYS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Penumbra, Inc.
EXACT Sciences Corp.
QIAGEN NV
Insulet Corp.
Hologic, Inc.
The Cooper Cos., Inc.
Waters Corp.
Revvity, Inc.
Bio-Rad Laboratories, Inc.
Bruker Corp.
Teleflex, Inc.
Why is Bio-Rad Laboratories, Inc. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 2.18% over the last 5 years
2
The company has declared negative results in Mar'2025 after 3 consecutive positive quarters
  • PRE-TAX PROFIT(Q) Lowest at USD 82 MM
  • DEBT-EQUITY RATIO (HY) Highest at 0.43 %
  • INVENTORY TURNOVER RATIO(HY) Lowest at 1.48 times
3
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -3.59%, its profits have risen by 69.4% ; the PEG ratio of the company is 0.1
4
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -3.59% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Bio-Rad Laboratories, Inc. for you?

High Risk, Medium Return

Absolute
Risk Adjusted
Volatility
Bio-Rad Laboratories, Inc.
-5.43%
0.29
44.28%
S&P 500
13.22%
0.64
20.20%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
2.18%
EBIT Growth (5y)
2.95%
EBIT to Interest (avg)
30.77
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.06
Sales to Capital Employed (avg)
0.29
Tax Ratio
21.31%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
4.97%
ROE (avg)
11.09%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
5
Industry P/E
Price to Book Value
0.91
EV to EBIT
16.72
EV to EBITDA
10.62
EV to Capital Employed
0.90
EV to Sales
2.21
PEG Ratio
0.07
Dividend Yield
NA
ROCE (Latest)
5.38%
ROE (Latest)
17.30%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

5What is working for the Company
OPERATING CASH FLOW(Y)

Highest at USD 534.18 MM

ROCE(HY)

Highest at 4.59%

-16What is not working for the Company
PRE-TAX PROFIT(Q)

Lowest at USD 82 MM

DEBT-EQUITY RATIO (HY)

Highest at 0.43 %

INVENTORY TURNOVER RATIO(HY)

Lowest at 1.48 times

NET PROFIT(Q)

Lowest at USD 62.95 MM

Here's what is working for Bio-Rad Laboratories, Inc.
Operating Cash Flow
Highest at USD 534.18 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Depreciation
Highest at USD 50.6 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (USD MM)

Here's what is not working for Bio-Rad Laboratories, Inc.
Net Profit
At USD 62.95 MM has Fallen at -78.21%
over average net sales of the previous four periods of USD 288.9 MM
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (USD MM)

Pre-Tax Profit
Lowest at USD 82 MM and Fallen
In each period in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Net Profit
Lowest at USD 62.95 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is negative

Net Profit (USD MM)

Debt-Equity Ratio
Highest at 0.43 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Inventory Turnover Ratio
Lowest at 1.48 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."